| GTO ID | GTC3743 |
| Trial ID | NCT06238336 |
| Disease | Hematological Malignancy |
| Therapy | CAR-T cell |
| Treatment | CAR-T cells |
| Phase | Phase2|Phase3 |
| Recruitment status | Recruiting |
| Title | Clinical Study of CAR-T Technology for the Treatment of Relapsed Refractory Malignant Haematological Tumours |
| Year | 2020 |
| Country | China |
| Company sponsor | Shanxi Bethune Hospital |
| Other ID(s) | YXLL-2019-114 |
| Cohort 1 | |||||||||||
|
|||||||||||